Clinicopathologic features of invasive breast cancer (BC) diagnosed in carriers of germline PALB2, CHEK2 and ATM pathogenic variants.

被引：0
|
作者：
Scott, Danika
Kingham, Kerry
Hodan, Rachel
Ma, Cindy
Mills, Meredith
Ford, James M.
Kurian, Allison W.
Telli, Melinda L.
机构：
[1] Stanford Univ, Sch Med, Stanford, CA USA
[2] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA USA
[3] Stanford Hlth Care, Stanford, CA USA
[4] Stanford Univ, Sch Med, Stanford Canc Inst, Palo Alto, CA 94304 USA
[5] Stanford Univ, Stanford, CA 94305 USA
[6] Stanford Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1549
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Breast cancer screening for carriers of ATM, CHEK2, and PALB2 pathogenic variants: A comparative modeling analysis.
    Lowry, Kathryn P.
    Geuzinge, H. Amarens
    Stout, Natasha K.
    Alagoz, Oguzhan
    Hampton, John M.
    Kerlikowske, Karla
    Miglioretti, Diana L.
    Schecter, Clyde
    Sprague, Brian L.
    Trentham-Dietz, Amy
    Tosteson, Anna N. A.
    Van Ravesteyn, Nicolien
    Yaffe, Martin
    Yeh, Jennifer
    Couch, Fergus
    Kraft, Peter
    Polley, Eric
    Mandelblatt, Jeanne S.
    Kurian, Allison W.
    Robson, Mark E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
    Yadav, Siddhartha
    Boddicker, Nicholas J.
    Na, Jie
    Polley, Eric C.
    Hu, Chunling
    Hart, Steven N.
    Gnanaolivu, Rohan D.
    Larson, Nicole
    Holtegaard, Susan
    Huang, Huaizhi
    Dunn, Carolyn A.
    Teras, Lauren R.
    Patel, Alpa V.
    Lacey, James V.
    Neuhausen, Susan L.
    Martinez, Elena
    Haiman, Christopher
    Chen, Fei
    Ruddy, Kathryn J.
    Olson, Janet E.
    John, Esther M.
    Kurian, Allison W.
    Sandler, Dale P.
    O'Brien, Katie M.
    Taylor, Jack A.
    Weinberg, Clarice R.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Zirpoli, Gary
    Goldgar, David E.
    Palmer, Julie R.
    Domchek, Susan M.
    Weitzel, Jeffrey N.
    Nathanson, Katherine L.
    Kraft, Peter
    Couch, Fergus J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (09) : 1703 - +
  • [3] Real-world clinical characteristics and management of breast cancer in patients with germline pathogenic variants in ATM, CHEK2 and PALB2
    Brzeskiewicz, Laura
    Roscow, Breanna
    Beeks, April
    Kunz, Barb
    Ratzel, Sarah
    Slavin, Thomas
    Cummings, Shelly
    Tedesco, Karen
    Reid, Robert
    GENETICS IN MEDICINE, 2022, 24 (03) : S34 - S34
  • [4] Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
    Toss, Angela
    Tenedini, Elena
    Piombino, Claudia
    Venturelli, Marta
    Marchi, Isabella
    Gasparini, Elisa
    Barbieri, Elena
    Razzaboni, Elisabetta
    Domati, Federica
    Caggia, Federica
    Grandi, Giovanni
    Combi, Francesca
    Tazzioli, Giovanni
    Dominici, Massimo
    Tagliafico, Enrico
    Cortesi, Laura
    GENES, 2021, 12 (05)
  • [5] Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants A Comparative Modeling Analysis
    Lowry, Kathryn P.
    Geuzinge, H. Amarens
    Stout, Natasha K.
    Alagoz, Oguzhan
    Hampton, John
    Kerlikowske, Karla
    de Koning, Harry J.
    Miglioretti, Diana L.
    van Ravesteyn, Nicolien T.
    Schechter, Clyde
    Sprague, Brian L.
    Tosteson, Anna N. A.
    Trentham-Dietz, Amy
    Weaver, Donald
    Yaffe, Martin J.
    Yeh, Jennifer M.
    Couch, Fergus J.
    Hu, Chunling
    Kraft, Peter
    Polley, Eric C.
    Mandelblatt, Jeanne S.
    Kurian, Allison W.
    Robson, Mark E.
    JAMA ONCOLOGY, 2022, 8 (04) : 587 - 596
  • [6] Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations
    Colin Bergstrom
    Colton Pence
    Jordan Berg
    Natalia Partain
    Navid Sadeghi
    Caitlin Mauer
    Sara Pirzadeh-Miller
    Ang Gao
    Hsiao Li
    Nisha Unni
    Samira Syed
    Annals of Surgical Oncology, 2021, 28 : 3383 - 3393
  • [7] Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations
    Bergstrom, Colin
    Pence, Colton
    Berg, Jordan
    Partain, Natalia
    Sadeghi, Navid
    Mauer, Caitlin
    Pirzadeh-Miller, Sara
    Gao, Ang
    Li, Hsiao
    Unni, Nisha
    Syed, Samira
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3383 - 3393
  • [8] Oncotype DX Breast Recurrence Score® analysis in early-stage breast cancer associated with CHEK2, ATM and PALB2 germline pathogenic variants
    Mustafayev, Fatma Akkoc
    Barrera, Angelica Gutierrez
    Liu, Diane
    Arun, Banu
    CANCER RESEARCH, 2024, 84 (09)
  • [9] Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model
    Lee, Andrew J.
    Cunningham, Alex P.
    Tischkowitz, Marc
    Simard, Jacques
    Pharoah, Paul D.
    Easton, Douglas F.
    Antoniou, Antonis C.
    GENETICS IN MEDICINE, 2016, 18 (12) : 1190 - 1198
  • [10] Population-based Estimates of contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
    Yadav, Siddhartha
    Boddicker, Nicholas J.
    Na, Jie
    Polley, Eric C.
    Hu, Chunling
    Hart, Steven N.
    Gnanaolivu, Rohan D.
    Larson, Nicole
    Dunn, Carolyn
    Holtegaard, Susan
    Huang, Huaizhi
    Teras, Lauren R.
    Patel, Alpa V.
    Lacey, James V., Jr.
    Neuhausen, Susan
    Bernstein, Leslie
    Martinez, Elena
    Haiman, Christopher
    Chen, Fei
    Ruddy, Kathryn
    Olson, Janet
    John, Esther
    Kurian, Allison W.
    Sandler, Dale P.
    O'Brien, Katie M.
    Taylor, Jack A.
    Weinberg, Clarice R.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Zirpoli, Gary R.
    Goldgar, David E.
    Nathanson, Katherine L.
    Domchek, Susan
    Palmer, Julie R.
    Weitzel, Jeffrey
    Kraft, Peter
    Couch, Fergus J.
    CANCER RESEARCH, 2023, 83 (05)
12345